Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTC7A Inhibitors

TTC7A inhibitors are a class of chemical compounds that specifically target and inhibit the function of the Tetratricopeptide Repeat Domain 7A (TTC7A) protein. TTC7A is part of a family of proteins characterized by tetratricopeptide repeat (TPR) motifs, which are involved in mediating protein-protein interactions. TTC7A is known to play a critical role in regulating cellular functions such as protein trafficking, membrane dynamics, and cell structure maintenance, particularly in epithelial cells. This protein is involved in coordinating the assembly of complex protein networks that regulate cell polarization, adhesion, and signal transduction pathways. By inhibiting TTC7A, these compounds disrupt its ability to form necessary interactions, leading to changes in cellular organization and signaling processes.

Structurally, TTC7A inhibitors are designed to bind to the TPR domains or other critical regions of the protein that are essential for its interaction with other cellular proteins. By blocking these interactions, the inhibitors prevent TTC7A from carrying out its regulatory roles in cellular processes such as maintaining the integrity of the plasma membrane and organizing cytoskeletal elements. This inhibition provides researchers with tools to study the specific contributions of TTC7A to cellular homeostasis, particularly in the context of epithelial tissue dynamics. By altering TTC7A activity, researchers can investigate how this protein influences key processes like protein trafficking, membrane stability, and the organization of cellular junctions. Understanding the role of TTC7A through inhibition sheds light on the broader mechanisms of cell structure and function, particularly in tissues that rely on precise regulation of membrane dynamics and protein interactions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits protein synthesis, which may reduce TTC7A levels.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interferes with transcription, potentially lowering TTC7A mRNA levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

By inhibiting mTOR, it might affect protein synthesis, including TTC7A.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor that might affect signaling pathways regulating TTC7A expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that might influence pathways involved in TTC7A regulation.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MAPK, potentially affecting pathways that regulate TTC7A expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that might modify stress-related pathways affecting TTC7A expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, potentially affecting inflammatory responses that could modulate TTC7A expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor that might affect multiple pathways, possibly including those regulating TTC7A.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Inhibitor of ROCK, might influence cytoskeletal organization and pathways related to TTC7A.